Health

  • March 16, 2026

    GAO Rejects Unequal Evaluation Claim In CMS Contract

    The U.S. Government Accountability Office found the Centers for Medicare and Medicaid Services did not treat a technology contractor unequally by giving it a low-confidence rating in the technical category even though the winning bidder had time-management issues.

  • March 16, 2026

    Triton Clinches €5.5B For 6th Fund In Largest Raise To Date

    European middle-market private equity shop Triton Partners, led by Simpson Thacher & Bartlett LLP, on Monday revealed that it closed its sixth flagship mid-market fund with €5.5 billion ($6.3 billion) in tow, marking the firm's largest fundraise to date.

  • March 16, 2026

    Senior Housing REIT Janus Living Seeks $703M From IPO

    Senior housing-focused real estate investment trust Janus Living said Monday that it is seeking about $700 million in an initial public offering this week, advised by Latham & Watkins LLP and Sidley Austin LLP, that follows a carveout this year.

  • March 16, 2026

    Mass. City Accused Of Bias In Mental Health 911 Response

    The city of Worcester, Massachusetts, was hit with a suit Monday claiming that its 911 response is inadequate and discriminatory towards people with mental disabilities because the armed police who usually show up are ill-equipped to deal with those calls and often make matters worse.

  • March 13, 2026

    'Swinging Dicks' Dissent Stirs Uproar Across 9th Circ. Bench

    A raunchy dissent in litigation over transgender spa patrons prompted dozens of Ninth Circuit judges to denounce the "vulgar barroom talk" of a colleague, who returned fire by ridiculing his peers for adopting the "fastidious sensibilities of a Victorian nun."

  • March 13, 2026

    Cannabis Co. Loses Bid To Merge Rival's Suit With AI Fight

    A Florida federal judge has found "there is no basis to consolidate" two lawsuits between medical marijuana company Leafwell and its competitor My Florida Green, concluding Leafwell's lawsuit accusing My Florida Green's counsel of misusing artificial intelligence to wreck Leafwell's business doesn't substantially overlap with My Florida Green's unfair business practice suit against Leafwell and others.

  • March 13, 2026

    Maryland Bros. Get Prison For HIV Drug Fraud Scheme

    A Florida federal judge on Friday sentenced two Maryland brothers to prison for their roles in a fraudulent medication scheme that involved selling misbranded HIV drugs with fake tracing documents to pharmacies and patients. 

  • March 13, 2026

    4th Circ. Brings Back Allergan Medicaid Overcharging Suit

    A split Fourth Circuit panel on Friday revived a whistleblower suit accusing an Allergan Sales LLC predecessor of overcharging Medicaid by more than $680 million, saying the whistleblower plausibly alleged the company knowingly improperly aggregated discounts into "best prices" for drugs.

  • March 13, 2026

    Conn. Statehouse Catch-Up: AI, Social Media, Private Equity

    Connecticut lawmakers are one-third of the way through the state's three-month legislative session, and already, bills targeting social media, artificial intelligence, prediction markets, private equity and hospital ownership are stacking up at the statehouse.

  • March 13, 2026

    Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar

    Sandoz Inc. is appealing after a Virginia federal court ruled it should have brought claims accusing Amgen of blocking competition for the Enbrel biosimilar in a previous patent dispute, according to a Friday notice. 

  • March 13, 2026

    Voyager Acquisition's 2nd SPAC Seeks To Raise $220M

    Special purpose acquisition company Voyager Acquisition II on Friday filed plans with U.S. regulators to raise up to $220 million in an initial public offering, with the goal of merging with an entity in the technology, fintech or healthcare sectors.

  • March 13, 2026

    Texas Justices Clear Way For State's Trans Care Probe

    An LGBTQ+ advocacy organization must produce documents as part of an investigation from the Texas attorney general's office into transgender treatments for minors, the Texas Supreme Court ruled on Friday, saying that the state's ban on gender-affirming care for minors is the law and must be followed. 

  • March 13, 2026

    Kroger Agrees To Pay $17M In Drug Copay Inflation Case

    Kroger pharmacy customers reached a $17 million settlement with the grocer resolving allegations that it inflated their copays for insured prescriptions, according to a motion for preliminary approval of the deal filed in Ohio federal court.

  • March 13, 2026

    J&J Unit Says Ex-Director Misappropriated Trade Secrets

    A Johnson & Johnson subsidiary has accused a former associate director of downloading over 7,000 files worth of confidential information prior to her resignation and using it to start her own competing company.

  • March 13, 2026

    UK Litigation Roundup: Here's What You Missed In London

    In London, Estée Lauder accused Jo Malone's founder of intellectual property infringement, the wife of an Iranian businessman linked to a £75 million fraud sued several Iranian oil companies, HSBC sued U.S. property tycoon Michael Fuchs, and Charles Russell Speechlys brought a claim against a United Arab Emirates company it once represented in an international arbitration.

  • March 13, 2026

    Drug Co. Moves To Sanction Insurer Over Destroyed Evidence

    A drug wholesaler seeking coverage for underlying opioid litigation urged an Illinois federal court to sanction its insurer for destroying key emails and underwriting records, saying the carrier failed to update a litigation hold or suspend its automatic deletion policies and then attempted to hide the issue during discovery.

  • March 13, 2026

    EPA Aims To Lift Biden-Era Ethylene Oxide Limits

    The U.S. Environmental Protection Agency on Friday proposed rolling back limits on emissions of ethylene oxide, a carcinogenic chemical used in the sterilization of medical devices.

  • March 13, 2026

    Tort Report: Uber Won't OK Bigger Jury At 2nd Bellwether

    Trial strategy by Uber ahead of a second bellwether trial in sexual assault multidistrict litigation and a $4 million injury verdict against Publix in Florida lead Law360's Tort Report, which compiles recent personal injury and medical malpractice news that may have flown under the radar.

  • March 12, 2026

    Ariz. Docs Ink $4.75M FCA Deal Over Unnecessary Treatment

    An Arizona-based physician group that offers cardiology and vascular services has inked a $4.75 million settlement to resolve False Claims Act allegations they performed unnecessary vein ablations and submitted claims for payment to government healthcare programs for reimbursement, the U.S. Department of Justice said Thursday.

  • March 12, 2026

    Top Texas Court Upholds Death Sentence For ICU Nurse

    The Texas Court of Criminal Appeals on Thursday affirmed the death sentence of a former cardiovascular nurse convicted of intentionally murdering patients recovering from operations, finding that Texas prosecutors' accusation that defense counsel engaged in "misdirection and deception" was "mild."

  • March 12, 2026

    DC Circ. Spends Hours Debating 'Same' Generic Label Reqs

    The D.C. Circuit spent more than three hours Thursday going round with Vanda Pharmaceuticals and the U.S. Food and Drug Administration about whether the label for a generic sleep-wake disorder medication is "the same" as the branded one because it doesn't include Braille.

  • March 12, 2026

    Wash. Justices OK Jury Instruction In TB Malpractice Case

    The Washington State Supreme Court declined Thursday to flip a family's loss in a case blaming an Evergreen State doctor for failing to address signs of an intestinal tuberculosis infection that led to a patient's death, rejecting a challenge to a jury instruction on the physician's exercise of judgment.

  • March 12, 2026

    Colo. Panel Clarifies Workers Comp Law On Maintenance Care

    In interpreting the Colorado Workers' Compensation Act, the Colorado Court of Appeals ruled for the first time Thursday that employers and their insurers cannot limit maintenance medical benefits to any specific treatment in a final admission of liability.

  • March 12, 2026

    Insurer Asks NC Justices To Free It From Captive Carrier Row

    A Georgia insurance company told North Carolina's highest court that the state's Business Court doesn't have jurisdiction over it in a shareholder dispute over the demise of a defunct captive insurer, arguing it had nothing to do with the supposed bad acts of its individual members.

  • March 12, 2026

    Embryo Loss Suits Need 'Serious' Edits, Judge Told

    Two complaints against fertility products maker CooperSurgical Inc. require "serious" amendments to clarify the nature of the claims that a defective culture medium caused embryo losses for in vitro fertilization patients, the company told a Connecticut federal judge Thursday.

Expert Analysis

  • Health Co.'s 'Success Story' Misstep Holds HIPAA Lessons

    Author Photo

    Cadia Healthcare Facilities' fall settlement with the U.S. Department of Health and Human Services for improperly disclosing patients' protected health information in online success stories is an instructive example of Health Insurance Portability and Accountability Act risks that can arise from digital marketing efforts, say attorneys at Woods Rogers.

  • Opinion

    AI-Assisted Arbitration Needs Safeguards To Ensure Fairness

    Author Photo

    As tribunals and arbitral institutions increasingly use artificial intelligence tools in their decision-making processes, ​​​​​​​clear disclosure standards and procedural safeguards are necessary to ensure that efficiency gains do not erode the fairness principles on which arbitration depends, says Alexander Lima at Wesco International.

  • Trans Care Enforcement Landscape Is Evolving Quickly

    Author Photo

    The recent coordinated federal effort to reshape pediatric gender-affirming care through enforcement and funding pressure has created a rapidly evolving regulatory environment marked by shifting risk assessments and potential downstream market effects for healthcare institutions and life sciences companies, say attorneys at Arnall Golden.

  • Series

    Playing Piano Makes Me A Better Lawyer

    Author Photo

    Playing piano and practicing law share many parallels relating to managing complexity: Just as hearing an entire musical passage in my head allows me to reliably deliver the message, thinking about the audience's impression helps me create a legal narrative that keeps the reader engaged, says Michael Shepherd at Fish & Richardson.

  • 11th Circ. May Bring Tectonic Shift To FCA Qui Tam Actions

    Author Photo

    The Eleventh Circuit's upcoming decision in Zafirov v. Florida Medical Associates, assessing whether the False Claims Act permits ordinary citizens to stand as officers of the federal government, could significantly limit private relators' ability to bring FCA actions, say attorneys at Saul Ewing.

  • AI-Generated Doc Ruling Guides Attys On Privilege Risks

    Author Photo

    A New York federal court's ruling, in U.S. v. Heppner, that documents created by a defendant using an artificial intelligence tool were not privileged, can serve as a guide to attorneys for retaining attorney-client or work-product privilege over client documents created with AI, say attorneys at Sher Tremonte.

  • To Survive FCA Actions, Small Cos. Must Take Offensive Steps

    Author Photo

    A fumbled response to False Claims Act allegations can doom lower-middle-market businesses, and with FCA enforcement hitting record levels for two years, smaller companies must have offensive strategies ready that focus their limited resources on defeating civil qui tam and federal criminal actions, says Derrelle Janey at Olshan Frome.

  • The Law Firm Merger Diaries: Leadership Strategy After Day 1

    Author Photo

    For law firm leaders, ensuring a newly combined law firm lives up to its promise, both in its first days of operation and well after, includes tough decisions, clear and specific communication, and cheerleading, says Peter Michaud at Ballard Spahr.

  • How US Liability Law Is Becoming The Primary Regulator Of AI

    Author Photo

    Comprehensive federal AI regulation remains fragmented and uncertain — but U.S. courts, applying long-standing doctrines of liability and responsibility, are actively shaping how AI systems are designed, deployed and governed, and companies are aligning their AI practices because courts may hold them accountable if they do not, says Alexander Lima at Wesco International.

  • Record FCA Recoveries Signal Intensified Healthcare Focus

    Author Photo

    In its recently released False Claims Act statistics, the U.S. government's emphasis on record healthcare recoveries and government-initiated healthcare matters last year indicates robust enforcement ahead, though the administration's focus on current policy objectives also extends beyond the healthcare sector, say attorneys at Epstein Becker.

  • Fed. Circ. In Jan.: On The Validity Of Expert Testimony

    Author Photo

    The Federal Circuit's recent decision in Barry v. DePuy, addressing whether expert testimony is admissible even if it does not strictly adhere to the court's claim construction, suggests that exclusion via a Daubert motion is appropriate only when the line to improper testimony is clearly crossed, say attorneys at Knobbe Martens.

  • Methods For Challenging State Civil Investigative Demands

    Author Photo

    Ongoing challenges to enforcement actions underscore the uphill battle businesses face in arguing that a state investigation is prohibited by federal law, but when properly deployed, these arguments present a viable strategy to resist civil investigative demands issued by state attorneys general, say attorneys at Troutman Pepper.

  • Calif.'s Civility Push Shows Why Professionalism Is Vital

    Author Photo

    The California Bar’s campaign against discourteous behavior by attorneys, including a newly required annual civility oath, reflects a growing concern among states that professionalism in law needs shoring up — and recognizes that maintaining composure even when stressed is key to both succeeding professionally and maintaining faith in the legal system, says Lucy Wang at Hinshaw.

  • A Potential Shift In FDA's Approach To Drug Trial Design

    Author Photo

    Recent guidance released by the U.S. Food and Drug Administration clarifying how Bayesian approaches — which combine prior knowledge with new data — may be used in clinical trials reflects the agency's continued interest in innovative trial designs that may accelerate drug approvals, say attorneys at Alston & Bird.

  • Opinion

    SNAP Rule Confusion Risks A Compliance Crisis

    Author Photo

    Recent Supplemental Nutrition Assistance Program food restriction waivers pose a compliance crisis for legal practitioners advising food retailers, amid higher costs and lack of a coherent national standard, says Tyson-Lord Gray at Yeshiva University’s Benjamin N. Cardozo School of Law.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.